Global menu

Our global pages

Close

Eversheds Sutherland Ltd successfully advised mybacs GmbH in second financing round

  • Switzerland

    27-08-2020

    Eversheds Sutherland Ltd has successfully advised mybacs GmbH in its second financing round with several new and existing international investors. mybacs GmbH is a biotechnology startup specializing in the human microbiome and intestinal health.

    The team of Eversheds Sutherland Ltd consisted of Oliver Beldi (partner, corporate / M&A) and Sandra Boegli (legal director, corporate / M&A).

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back